Neurocrine Biosciences Inc (NAS:NBIX)
$ 141.08 -0.92 (-0.65%) Market Cap: 14.20 Bil Enterprise Value: 13.60 Bil PE Ratio: 38.87 PB Ratio: 5.95 GF Score: 89/100

Q1 2019 Neurocrine Biosciences Inc Earnings Call Transcript

Apr 29, 2019 / 08:30PM GMT
Release Date Price: $76.77 (-0.84%)
Operator

Hello, and thank you for joining the Neurocrine Biosciences Reports First Quarter 2019 Results. (Operator Instructions) Please note, this call may be recorded.

It is now my pleasure to turn the call over to Kevin Gorman, CEO. Please go ahead.

Kevin C. Gorman
Neurocrine Biosciences, Inc. - CEO & Director

Thank you very much, and thank you, everyone, for joining us this afternoon. Here, I'm joined with -- by Matt Abernethy, our CFO; Eiry Roberts, our CMO; Eric Benevich, our Chief Commercial Officer; and also, Kyle Gano, our Chief Business Development Officer.

Before I get started, Jane, will you please read our safe harbor statement?

Jane Sorensen
Neurocrine Biosciences, Inc. - Head of IR

Yes, good afternoon. Certain statements made in the course of this conference call that are not historical statements may be forward-looking statements, which are subject to risks and uncertainties. Information concerning factors that could cause actual results to differ materially from those contained in or

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot